Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Frankel

Showing results (231-240 of 259) with videos related to

Pageof 26
Sort By:
Molecular Cancer Therapeutics|January 8, 2010
Inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin in an orthotopic model of anaplastic thyroid carcinomaRandall W Alfano, Stephen H Leppla, Shihui Liu, et al.
Microbial Pathogenesis|January 29, 2008
Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhageShu-Ru Kuo, Mark C Willingham, Sarah H Bour, et al.
Protein Expression and Purification|December 19, 2003
Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trialsJeffrey O Urieto, TieFu Liu, Jennifer H Black, et al.
Molecular Cancer Research : MCR|April 18, 2009
Matrix metalloproteinase-activated anthrax lethal toxin inhibits endothelial invasion and neovasculature formation during in vitro morphogenesisRandall W Alfano, Stephen H Leppla, Shihui Liu, et al.
Leukemia & Lymphoma|December 17, 2002
Efficacy and safety of gemtuzumab ozogamicin in patients with poor-prognosis acute myeloid leukemiaG J Roboz, M A Knovich, R L Bayer, et al.
The Journal of Dermatologic Surgery and Oncology|April 1, 1987
Thickness of malignant melanoma: global analysis of related factorsA W Kopf, B Welkovich, R E Frankel, et al.
Leukemia|May 23, 2001
Oncogene-dependent engraftment of human myeloid leukemia cells in immunosuppressed miceM Kiser, J A McCubrey, L S Steelman, et al.
Molecular Cancer Therapeutics|March 6, 2008
Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcomaYan Ding, Elissa A Boguslawski, Bree D Berghuis, et al.
International Journal of Oncology|March 25, 2008
The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contributionCecile Rouleau, Krishna Menon, Paula Boutin, et al.
Toxicology and Applied Pharmacology|July 17, 1999
Toxicology and pharmacokinetics of DTGM, a fusion toxin consisting of a truncated diphtheria toxin (DT388) linked to human granulocyte-macrophage colony-stimulating factor, in cynomolgus monkeysC E Hotchkiss, P D Hall, J M Cline, et al.
Pageof 26

Showing results (231-240 of 259) with videos related to

Sort By:
Pageof 26
Molecular Cancer Therapeutics|January 8, 2010
Inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin in an orthotopic model of anaplastic thyroid carcinomaRandall W Alfano, Stephen H Leppla, Shihui Liu, et al.
Microbial Pathogenesis|January 29, 2008
Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhageShu-Ru Kuo, Mark C Willingham, Sarah H Bour, et al.
Protein Expression and Purification|December 19, 2003
Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trialsJeffrey O Urieto, TieFu Liu, Jennifer H Black, et al.
Molecular Cancer Research : MCR|April 18, 2009
Matrix metalloproteinase-activated anthrax lethal toxin inhibits endothelial invasion and neovasculature formation during in vitro morphogenesisRandall W Alfano, Stephen H Leppla, Shihui Liu, et al.
Leukemia & Lymphoma|December 17, 2002
Efficacy and safety of gemtuzumab ozogamicin in patients with poor-prognosis acute myeloid leukemiaG J Roboz, M A Knovich, R L Bayer, et al.
The Journal of Dermatologic Surgery and Oncology|April 1, 1987
Thickness of malignant melanoma: global analysis of related factorsA W Kopf, B Welkovich, R E Frankel, et al.
Leukemia|May 23, 2001
Oncogene-dependent engraftment of human myeloid leukemia cells in immunosuppressed miceM Kiser, J A McCubrey, L S Steelman, et al.
Molecular Cancer Therapeutics|March 6, 2008
Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcomaYan Ding, Elissa A Boguslawski, Bree D Berghuis, et al.
International Journal of Oncology|March 25, 2008
The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contributionCecile Rouleau, Krishna Menon, Paula Boutin, et al.
Toxicology and Applied Pharmacology|July 17, 1999
Toxicology and pharmacokinetics of DTGM, a fusion toxin consisting of a truncated diphtheria toxin (DT388) linked to human granulocyte-macrophage colony-stimulating factor, in cynomolgus monkeysC E Hotchkiss, P D Hall, J M Cline, et al.
Pageof 26